Advertisement
Advertisement
U.S. markets open in 4 hours 45 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.9000-0.5800 (-23.39%)
At close: 04:00PM EDT
1.9100 +0.01 (+0.53%)
After hours: 07:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close2.4800
Open2.5000
Bid1.8700 x 1200
Ask0.0000 x 900
Day's Range1.8700 - 2.5300
52 Week Range1.8700 - 7.1300
Volume518,784
Avg. Volume113,022
Market Cap58.753M
Beta (5Y Monthly)-0.56
PE Ratio (TTM)N/A
EPS (TTM)-0.3400
Earnings DateMay 10, 2023 - May 15, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
193% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CODX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Co-Diagnostics, Inc.
    VIR: What does Argus have to say about VIR?VIR BIOTECHNOLOGY INC has an Investment Rating of HOLD; a target price of $24.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • Insider Monkey

    Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript

    Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note that this event is […]

  • PR Newswire

    Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 10th Gene Quantification Event held March 20-24 at the Technical University of Munich. Dr. Carl Wittwer, Chair of the Company's Scientific Advisory Board (SAB) will also be presenting at the event.

  • Thomson Reuters StreetEvents

    Q4 2022 Co-Diagnostics Inc Earnings Call

    Q4 2022 Co-Diagnostics Inc Earnings Call

Advertisement
Advertisement